RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: cutaneous leishmaniasis
Accession: DOID:9111
browse the term
Definition: A leishmaniasis that involves skin infection caused by Leishmania species, resulting in one or more cutaneous lesions. (DO)
Synonyms: exact_synonym: American Leishmaniasis; Asian desert cutaneous leishmaniasis; Cutaneous Leishmaniases; New World Leishmaniasis; Old World Leishmaniasis; Oriental Sore; leproid leishmaniasis
primary_id: MESH:D016773
xref: EFO:0005046 ; ICD10CM:B55.1 ; NCI:C34768
G
CAT
catalase
ISO
protein:decreased activity:erythrocyte:
RGD
PMID:9892499
RGD:9479188
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr 9:39,008,187...39,009,932
G
CCR1
chemokine (C-C motif) receptor 1
ISO
RGD
PMID:12874303
RGD:5688168
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:foot, lymph node
RGD
PMID:12874303
RGD:5688168
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
G
CCR5
C-C motif chemokine receptor 5
no_association
ISO
DNA:frameshift mutation: :p.S185_T195del (rs333) (human)
RGD
PMID:17214851 PMID:23632983
RGD:8549764 RGD:8549765
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CD163
CD163 molecule
ISO
mRNA, protein:increased expression:skin of body, blood plasma, CD14-positive monocyte (human)
RGD
PMID:32023254
RGD:127345130
NCBI chr27:37,669,757...37,700,746
Ensembl chr27:37,669,827...37,753,106
G
CD274
CD274 molecule
ISO
RGD
PMID:16358363
RGD:41410801
NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522
G
COL1A1
collagen type I alpha 1 chain
ISO
DNA:SNPs: :rs1061237, rs2586488 (human)
RGD
PMID:25562121
RGD:11041176
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
FOXP3
forkhead box P3
ISO
mRNA:increased expression:Peripheral blood mononuclear cell:
RGD
PMID:29205403
RGD:38455981
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
G
IFNG
interferon gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8154019 PMID:9234779 PMID:20102417 PMID:27999013
RGD:40890273
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:Peripheral blood mononuclear cell:
CTD RGD
PMID:20102417 PMID:29205403
RGD:38455981
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:12739821 PMID:18924210
RGD:8549536 RGD:8549561
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
IL17A
interleukin 17A
ISO
mRNA:increased expression:Peripheral blood mononuclear cell:
RGD
PMID:29205403
RGD:38455981
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:29078003
RGD:39457938
NCBI chr10:635,384...640,715
Ensembl chr10:638,719...640,359
G
IL32
interleukin 32
ameliorates susceptibility
ISO
DNA:SNPs:enhancers: (rs4786370, rs4349147) (human)
RGD
PMID:28709468 PMID:32023240
RGD:150340717 RGD:150340742
NCBI chr 6:38,119,287...38,122,979
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
KLRK1
killer cell lectin like receptor K1
treatment
ISO
associated with lymphocytic choriomeningitis
RGD
PMID:26290604
RGD:39128165
NCBI chr27:35,634,938...35,658,978
Ensembl chr27:35,639,280...35,658,882
G
LTA
lymphotoxin alpha
no_association
ISO
DNA:SNP:intron:252A>G (human)
RGD
PMID:16950634
RGD:8548800
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
G
LTB
lymphotoxin beta
ISO
RGD
PMID:17911622
RGD:8548820
NCBI chr12:1,079,340...1,084,785
Ensembl chr12:1,079,358...1,081,153
G
MMP2
matrix metallopeptidase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21091666
RGD:8657030
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
PDCD1LG2
programmed cell death 1 ligand 2
ISO
RGD
PMID:16358363
RGD:41410801
NCBI chr 1:93,631,676...93,698,560
Ensembl chr 1:93,631,979...93,689,266
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
treatment
ISO
RGD
PMID:27999013
RGD:40890273
NCBI chr 5:62,884,596...62,936,882
Ensembl chr 5:62,909,009...62,935,971
G
SLC11A1
solute carrier family 11 member 1
ISO
DNA:insertion/deletion (human)
RGD
PMID:20089160
RGD:5684930
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
SOD1
superoxide dismutase 1
ISO
protein:increased activity:erythrocyte:
RGD
PMID:9892499
RGD:9479188
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:10458767
RGD:8661703
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
TLR2
toll like receptor 2
ISO
protein:decreased expression:skin:
RGD
PMID:20493664
RGD:7794748
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR4
toll like receptor 4
ISO
protein:decreased expression:skin:
RGD
PMID:20493664
RGD:7794748
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TLR9
toll like receptor 9
ISO
protein:decreased expression:skin:
RGD
PMID:20493664
RGD:7794748
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TNF
tumor necrosis factor
no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-308G>A (rs1800629) (human)
CTD RGD
PMID:16950634 PMID:20102417
RGD:8548800
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7854095
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
LTA
lymphotoxin alpha
ISO
DNA:polymorphism:intron
RGD
PMID:7595196
RGD:8548799
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
G
TNF
tumor necrosis factor
ISO
DNA:SNP:promoter:-308G>A (human)
RGD
PMID:7595196
RGD:8548799
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all